Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 DOVU DOVU +48.06%
#3 Akedo Akedo +42.30%
#4 Velvet Velvet +37.91%
#5 Black Phoenix Black Phoenix +34.36%
#6 Cross Cross +17.98%
#7 DoubleZero DoubleZero +17.92%
#8 Cap Cap +14.84%
#9 Tutorial Tutorial +10.61%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.25%
Coin of the day
Islamic Coin Islamic Coin
Ρυθμίσεις
Γλώσσα
Ελληνικά
Νόμισμα
USD
Θέμα
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Κατάταξη σε μετοχές #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Τιμή μετοχής
$0.11725176
Τελευταίος συγχρονισμός: 2025-07-14
Κεφαλαιοποίηση
$481.50K
Αλλαγή (1 ημέρα)
-0.20%
Αλλαγή (1 έτος)
0.00%
Χώρα
FR
Εμπόριο PHAXIAM Therapeutics S.A. (PHXM)

Κατηγορία

Healthcare
Δείκτης P/B για PHAXIAM Therapeutics S.A. (PHXM)
Δείκτης P/B στις August 2026 TTM: 0.02
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της PHAXIAM Therapeutics S.A., ο τρέχων δείκτης P/B (TTM) είναι 0.02. Στο τέλος του 2022, η εταιρεία είχε P/B δείκτη 0.48.
Ιστορικό P/B για την PHAXIAM Therapeutics S.A. από 2016 έως 2026
Δείκτης P/B στο τέλος κάθε έτους
Έτος Δείκτης P/B Αλλαγή
2026 (TTM) 0.02 -97.64%
2023 0.78 60.84%
2022 0.48 -77.96%
2021 2.20 -55.37%
2020 4.93 250.70%
2019 1.40 82.40%
2018 0.77 -33.59%
2017 1.16 -62.33%
2016 3.08 0.00%
Δείκτης P/B για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Δείκτης P/B Διαφορά Δείκτη P/B Χώρα
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 33,928.80%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 34,401.63%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 19,650.00%
BE